Publication | Open Access
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
22
Citations
34
References
2023
Year
NCT02854072.
| Year | Citations | |
|---|---|---|
Page 1
Page 1